IP Library Patent Application 11536194
Patent Application
App. No. 11/536,194

CAPSULE-TYPE DRUG-RELEASING DEVICE AND CAPSULE-TYPE DRUG-RELEASING DEVICE SYSTEM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/536,194
Abstract

A capsule-type drug-releasing device is capable of freely controlling the release and stoppage of a drug and causing neither the back flow of contents of a stomach, an intestine, or the like nor clogging with the contents. A capsule-type drug-releasing device may include: a capsule-shaped casing; a cation exchange membrane arranged on the surface of the casing; a drug solution holding portion arranged inside the casing and on the inner side of the cation exchange membrane; an anion exchange membrane arranged on the inner side of the drug solution holding portion; an electrolyte solution holding portion arranged on the inner side of the anion exchange membrane; an electrode arranged on the inner side of the electrolyte solution holding portion; an electric power source connected to the electrode; a control portion capable of controlling energization from the electric power source to the electrode; and a transceiver portion causing the control portion to receive a signal from the outside of an organism.

Claims (29)

1 . A capsule-type drug release apparatus, comprising:

a housing in a shape of a capsule;

a first ion exchange member capable of selectively passing an ion of a first polarity therethrough, the first ion exchange member being disposed on a surface of the housing in the shape of a capsule;

a drug solution holding portion disposed in the housing and inside the first ion exchange member for holding a drug ion of the first polarity;

a second ion exchange member disposed further inside the drug solution holding portion, the second ion exchange member being capable of selectively passing an ion of a second polarity therethrough, the second polarity different from the first polarity;

an electrolyte solution holding portion disposed further inside the second ion exchange member;

electrodes disposed further inside the electrolyte solution holding portion;

an electric power source connected to the electrodes;

a control portion capable of controlling energization/disenergization from the electric power source to the electrodes; and

a receiving portion where the control portion receives a signal from the outside of an organism.

2 . The capsule-type drug release apparatus according to claim 1 , further comprising a transmitting portion capable of transmitting a signal from the control portion to the outside of the organism.

3 . The capsule-type drug release apparatus according to claim 1 , wherein each of the ion exchange members is formed of an ion exchange membrane.

4 . The capsule-type drug release apparatus according to claim 3 , further comprising a transmitting portion capable of transmitting a signal from the control portion to the outside of the organism.

5 . A capsule-type drug release apparatus system, characterized by comprising:

a capsule-type drug release apparatus comprising at least

a housing in a shape of a capsule,

a first ion exchange member capable of selectively passing an ion of a first polarity therethrough, the first ion exchange member being disposed on a surface of the housing in the shape of a capsule,

a drug solution holding portion disposed in the housing and inside the first ion exchange member for holding a drug ion of the first polarity,

a second ion exchange member disposed further inside the drug solution holding portion, the second ion exchange member being capable of selectively passing an ion of a second polarity therethrough,

an electrolyte solution holding portion disposed further inside the second ion exchange member,

electrodes disposed further inside the electrolyte solution holding portion,

an electric power source connected to the electrodes,

a control portion capable of controlling energization from the electric power source to the electrodes, and

a receiving portion where the control portion receives a signal from the outside of an organism;

position determining means capable of determining a position of the capsule-type drug release apparatus in the organism; and

transmitting means capable of transmitting a signal from the outside of the organism, the signal being received by the receiving portion.

6 . The capsule-type drug release apparatus system according to claim 5 wherein

the capsule-type drug release apparatus further comprises a transmitting portion capable of transmitting a signal from the control portion to the outside of the organism, and

the capsule-type drug release apparatus system further comprises receiving means capable of receiving a signal outside the organism, the signal being transmitted by the transmitting portion.

Assignments (5)
RESCISSION OF PRIOR ASSIGNMENT Recorded Mar 10, 2008
From: TRANSCU LTD.
To: TTI ELLEBEAU, INC.
Reel/Frame 020626/0021 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2007
From: TTI ELLEBEAU, INC.
To: TRANSCU LTD.
Reel/Frame 020236/0175 →
CHANGE OF NAME Recorded Dec 7, 2007
From: ELLEBEAU, INC.
To: TTI ELLEBEAU, INC.
Reel/Frame 020214/0336 →
MERGER Recorded Dec 5, 2007
From: TRANSCUTANEOUS TECHNOLOGIES, INC.
To: ELLEBEAU, INC.
Reel/Frame 020200/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2006
From: AKIYAMA, HIDERO; NAKAYAMA, MIZUO; MATSUMURA, TAKEHIKO; MATSUMURA, AKIHIKO
To: TRANSCUTANEOUS TECHNOLOGIES INC.
Reel/Frame 018649/0978 →